Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 18, 2022

SELL
$7.12 - $20.24 $1,751 - $4,979
-246 Reduced 0.57%
43,078 $859,000
Q2 2022

Aug 15, 2022

BUY
$5.1 - $10.0 $73,603 - $144,320
14,432 Added 49.95%
43,324 $299,000
Q1 2022

May 16, 2022

SELL
$8.34 - $14.69 $30,591 - $53,882
-3,668 Reduced 11.27%
28,892 $269,000
Q4 2021

Feb 15, 2022

BUY
$13.6 - $24.89 $9,724 - $17,796
715 Added 2.25%
32,560 $463,000
Q3 2021

Nov 15, 2021

SELL
$21.22 - $25.7 $264,825 - $320,736
-12,480 Reduced 28.16%
31,845 $738,000
Q2 2021

Aug 16, 2021

SELL
$22.86 - $30.95 $28,872 - $39,089
-1,263 Reduced 2.77%
44,325 $1.1 Million
Q1 2021

May 18, 2021

BUY
$24.58 - $42.82 $481,251 - $838,372
19,579 Added 75.28%
45,588 $1.28 Million
Q4 2020

Feb 16, 2021

BUY
$34.9 - $51.08 $56,468 - $82,647
1,618 Added 6.63%
26,009 $908,000
Q3 2020

Nov 17, 2020

BUY
$32.95 - $50.25 $803,683 - $1.23 Million
24,391 New
24,391 $1.22 Million

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.